Current CHS and NHBPEP Criteria for Severe Preeclampsia Do Not Uniformly Predict Adverse Maternal or Perinatal Outcomes

Objective: To determine the association between adverse maternal perinatal outcomes and Canadian and U.S. preeclampsia severity criteria. Methods: Using PIERS data (Preeclampsia Integrated Estimate of RiSk), an international continuous quality improvement project for women hospitalized with preeclam...

Full description

Saved in:
Bibliographic Details
Published in:Hypertension in pregnancy 2007-01, Vol.26 (4), p.447-462
Main Authors: Menzies, J., Magee, L. A., MacNab, Y. C., Ansermino, J. M., Li, J., Douglas, M. J., Gruslin, A., Kyle, P., Lee, S. K., Moore, M. P., Moutquin, J. M., Smith, G. N., Walker, J. J., Walley, K. R., Russell, J. A., von Dadelszen, P.
Format: Article
Language:English
Subjects:
Abruptio Placentae - classification
Adult
Adverse maternal outcome
Adverse perinatal outcome
Alanine Transaminase - blood
Aspartate Aminotransferases - blood
Canada
Chest Pain - classification
Cohort Studies
Creatinine - blood
Dyspnea - classification
Female
Fetal Diseases - classification
Forecasting
HELLP
HELLP Syndrome - classification
Humans
Infant, Newborn
L-Lactate Dehydrogenase - blood
Liver - enzymology
Pre-Eclampsia - classification
Prediction
Pregnancy
Pregnancy Outcome
Proteinuria
Risk Assessment
Severe preeclampsia
Severity of Illness Index
Thrombocytopenia
Thrombocytopenia - classification
United States
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective: To determine the association between adverse maternal perinatal outcomes and Canadian and U.S. preeclampsia severity criteria. Methods: Using PIERS data (Preeclampsia Integrated Estimate of RiSk), an international continuous quality improvement project for women hospitalized with preeclampsia, we examined the association between preeclampsia severity criteria and adverse maternal and perinatal outcomes (univariable analysis, Fisher's exact test). Not evaluated were variables performed in 110 μM) or perinatal outcomes (dBP >110 mm Hg and suspected abruption) (at p < 0.01). Conclusions: In the PIERS cohort, most factors used in the Canadian or American classifications of severe preeclampsia do not predict adverse maternal and or perinatal outcomes. Future classification systems should take this into account.
ISSN:1064-1955
1525-6065
DOI:10.1080/10641950701521742